Roche, Inovio to Develop Prostate Cancer, Hepatitis B Vaccines

Source: Miami Herald

Sep 10, 2013

Inovio Pharmaceuticals Inc. could earn more than $400 million through a partnership with Roche Holding AG to develop vaccines that target prostate cancer and hepatitis B. Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments